EBRCZ Revenue third quarter 2027 Y/Y Growth Comment
EBR Systems, Inc. reported Revenue surge of 387.65% year on year in the third quarter 2027, to $ 2.49 millions, this is lower than Ebr Systems, Inc.'s recent average Revenue surge of 919.78%.
According to the results reported in the third quarter 2027, Ebr Systems, Inc. achieved the best Revenue growth in Medical Equipment & Supplies industry. While Ebr Systems, Inc.' s Revenue doubling of 387.65% ranks overall at the positon no. 0 in the third quarter 2027.
Revenue by Quarter for the Fiscal Years 2024, 2025, 2026, 2027
Ebr Systems,'s Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
201.77 %
88.58 %
-5.69 %
(Sep 30 2025)
EBRCZ's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2027 Ebr Systems, Inc. disclosed decline in Revenue from the second quarter by -5.8% to $ 2.49 millions, from $ 2.64 millions achived in the previous reporting period.
Although periodic circumstance commonly energize III. Quarter 2027 Revenue, this plainly could not be substantial to rescue 's company achievement, Most analysts pointed out.
Within Medical Equipment & Supplies industry EBR Systems, Inc. achieved highest sequential Revenue growth. While Ebr Systems,'s Revenue growth quarter on quarter, overall rank is 0.
In the III. Quarter 2027 Ebr Systems, Inc. disclosed decline in Revenue from the second quarter by -5.8% to $ 2.49 millions, from $ 2.64 millions achived in the previous reporting period.
Although periodic circumstance commonly energize III. Quarter 2027 Revenue, this plainly could not be substantial to rescue 's company achievement, Most analysts pointed out.
Within Medical Equipment & Supplies industry EBR Systems, Inc. achieved highest sequential Revenue growth. While Ebr Systems,'s Revenue growth quarter on quarter, overall rank is 0.
Ebr Systems,'s 12 Months Revenue Growth Year on Year
Ebr Systems, saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 387.65% year on year, to $ 6 millions if the fiscal year would have ended in Jun 30 2026. Ebr Systems,'s trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2026. And, Ebr Systems, realized the fastest Revenue growth, in Medical Equipment & Supplies industry. But from twelve months ended Mar 31 2026 rise was beneth at 62.01 % from $3.98 millions achieved in the period from Mar 31 2026 to Jun 30 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 0%.
EBR Systems, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
Ebr Systems, saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 387.65% year on year, to $ 6 millions if the fiscal year would have ended in Jun 30 2026. Ebr Systems,'s trailing twelve months Revenue growth was higher than company's average 0% and higher than % growth in Mar 31 2026. And, Ebr Systems, realized the fastest Revenue growth, in Medical Equipment & Supplies industry. But from twelve months ended Mar 31 2026 rise was beneth at 62.01 % from $3.98 millions achieved in the period from Mar 31 2026 to Jun 30 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 0%. The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 62.01 % increase from $3.98 millions in the period from Mar 31 2026 to Jun 30 2025.
EBR Systems, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .
About Ebr Systems, Revenue Growth Rates (EBRCZ), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
588.43%